Histopathological characteristics and viral association with HIV-associated Multicentric Castleman's Disease (MCD) and with classical Castleman's Disease (cCD)

被引：0
|
作者：
Kloster, J. [1 ]
Hoffmann, C. [2 ]
Tiemann, M. [3 ]
机构：
[1] UKSH Campus Kiel, Kiel, Germany
[2] UKSH Campus Kiel, ICH Study Ctr, Hamburg, Germany
[3] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P256
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease
    Barker, Rob
    Kazmi, Fahrad
    Stebbing, Justin
    Ngan, Sarah
    Chinn, Roger
    Nelson, Mark
    O'Doherty, Michael
    Bower, Mark
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (04) : 648 - 652
  • [22] Relapse of HIV-associated multicentric Castleman's disease following rituximab-based immunotherapy
    Dalla Pria, Alessia
    Roe, Jennifer
    Bracchi, Margherita
    Pagani, Nicole
    McFaul, Katie
    Forni, John
    Merchant, Shairoz
    Samani, Amit
    Byrne, Ruth
    Nelson, Mark
    Bower, Mark
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [23] FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease
    Rob Barker
    Fahrad Kazmi
    Justin Stebbing
    Sarah Ngan
    Roger Chinn
    Mark Nelson
    Michael O’Doherty
    Mark Bower
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 648 - 652
  • [24] Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease
    Powles, Tom
    Stebbing, Justin
    Montoto, Silvia
    Nelson, Mark
    Gazzard, Brian
    Orkin, Chloe
    Webb, Andy
    Bower, Mark
    [J]. BLOOD, 2007, 110 (12) : 4132 - 4133
  • [25] Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease
    Angela Casquero
    Alicia Barroso
    Manuel L. Fernández Guerrero
    Miguel Górgolas
    [J]. Annals of Hematology, 2006, 85 : 185 - 187
  • [26] Bone marrow findings in multicentric Castleman's Disease not associated with HIV
    Kreft, A.
    Weber, A.
    Springer, E.
    Hess, G.
    Kirkpatrick, C. J.
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 392 - 392
  • [27] Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease
    Hoffmann, Christian
    Schmid, Holger
    Mueller, Markus
    Teutsch, Christian
    van Lunzen, Jan
    Esser, Stefan
    Wolf, Timo
    Wyen, Christoph
    Sabranski, Michael
    Horst, Heinz-August
    Reuter, Stefan
    Vogel, Martin
    Jaeger, Hans
    Bogner, Johannes
    Arasteh, Keikawus
    [J]. BLOOD, 2011, 118 (13) : 3499 - 3503
  • [28] Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease
    Alzahrani, Musa
    Hull, Mark C.
    Sherlock, Christopher
    Griswold, Deborah
    Leger, Chantal S.
    Jackson, Shannon
    Venner, Christopher P.
    Smith, Tyler W.
    Leitch, Heather A.
    [J]. BLOOD, 2010, 116 (21) : 1591 - 1592
  • [29] Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease
    Casquero, A
    Barroso, A
    Guerrero, MLF
    Górgolas, M
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (03) : 185 - 187
  • [30] HIV-associated multicentric Castleman’s disease after initiation of antiretroviral therapy: experience of a European centre
    J. Katchanov
    U. Zimmermann
    G. Branding
    K. Arastéh
    M. Müller
    [J]. Infection, 2014, 42 : 791 - 793
12345